
Changes in cerebral glucose metabolism in patients with mild-to-moderate Alzheimer's disease: A pilot study with the Chinese herbal medicine fuzhisan
Keywords: AD; Alzheimer's disease; FZS; fuzhisan; 18F-FDG-PET; 18F-2-fluoro-2-deoxy-d-glucose positron emission tomography; rCMRglc; regional cerebral metabolic rate of glucose consumption; ROIs; regions of interest; MRI; magnetic resonance imaging; ADAS-Cog; Alz